FATE News
Archived Headlines
- 13 US IPOs planned for the week of Sep 23 09/23/13
- 12 US IPOs planned for the week of Sep 16 09/16/13
- US IPO Recap: Benefitfocus, six others set terms as calendar rebuilds 09/08/13
- US IPO Recap: Two deals set terms, ten new filers added to the pipeline 09/03/13
- Orphan disease biotech Fate Therapeutics sets terms for $60 million IPO 09/03/13
See more
US IPO Recap: Twitter starts countdown to November offering, Potbelly pops
Twitter entered the final stages of its long-awaited offering, setting up what will likely be a pre-Thanksgiving debut, and sandwich shop chain Potbelly posted the second-best first-day return of the year in an eventful week for US IPOs. Consumer retailer...read more
Fate Therapeutics prices IPO at $6, at low end of the revised range
Fate Therapeutics, an early clinical-stage biotech developing stem cell treatments for orphan diseases, raised $40 million by offering 6.7 million shares at $6, the low end of the revised range of $6 to $8. The company had initially filed to offer 4.0 million...read more
Orphan disease biotech Fate Therapeutics decreases range and increases shares offered
Fate Therapeutics, an early clinical-stage biotech developing stem cell treatments for orphan diseases, lowered the proposed deal size for its upcoming IPO on Monday. The San Diego, CA-based company now plans to raise $47 million by offering 6.7 million shares...read more
9 US IPOs planned for the week of Sep 30
The following IPOs are expected to price this week: Burlington Stores (BURL), a national off-price retailer operating the Burlington Coat Factory Chain, plans to raise...read more